Latest filing published 03 Mar 2026 for Inogen Inc. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Gregoire Ramade, listed as senior executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Vapotherm Inc and Inogen Inc. In total, 11 filings cover trades dated from 28 July 2021 to 1 March 2026.
Purchases make up the whole of the open-market record (1 purchase, €5,232). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 3 share grants and 7 option exercises.
The record was last updated on 3 March 2026 with an option exercise in Inogen Inc. The latest purchase dates back some time: it was published 1,431 days ago, on 17 November 2022. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations